Clinical Investigation Exploring a Newly Developed Ostomy Baseplate.

Inclusion criteria

• Has given written informed consent
• Is at least 18 years old
• Has full legal capacity
• Has an ileostomy with consistent liquid faecal output (6-7 Bristol scale).
• Has used flat SenSura Mio 1-piece or 2-piece for at least 14 days before the inclusion.
• Has had the stoma for at least 90 days
• Has a stoma size less than 45mm in diameter
• Has experienced symptoms of peristomal skin complications such as itching, burning, or pain in the peristomal area within the last 14 days
• Has suitable peristomal skin area (assessed by investigator) to participate in investigation
• Is willing to refrain from analgesics within 24 hours before the test days
• Is willing to refrain from antihistamine within 96 hours before the test days
• Is willing to refrain from steroid treatment within 24 hours before the test days

Exclusion criteria

• Is currently receiving or have within the past 60 days received radio-and/or chemotherapy.
• low doses radio- and/or chemotherapy (assessed by Principal Investigator) is allowed for other indications than cancer.
• Is currently receiving or have within the past 30 days received topical steroid treatment in the peristomal skin area, e.g., lotion or spray.
• Is breastfeeding
• Is pregnant based on urine pregnancy test.
• Has known hypersensitivity towards any of the devices used in the investigation.
• Participates in other clinical investigations. Exception: Participation in other Coloplast sponsored clinical investigations is accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and exclusion criteria of this protocol